News

Botulinum Toxin A for the Treatment of Chronic Lumbar Back Pain

2008-11-06


One hundred sixty subjects will be randomly assigned to one of four arms (placebo/placebo, placebo/Botox, Botox/placebo, Botox/Botox). In the first of two phases, randomized subjects will blindly receive either Botox® (study arms Botox/placebo and Botox/Botox) or placebo (study arms placebo/placebo and placebo/Botox) injection into the lumbar paraspinal muscles. The subjects will be assessed using validated scales for pain and disability prior to injection and monthly thereafter for four months. In the second phase, a second set of lumbar injections will be administered based on the initial randomization and will blindly receive either Botox® (study arms placebo/Botox and Botox/Botox) or placebo (study arms placebo/placebo and Botox/placebo) injection into the lumbar paraspinal muscles. The subjects will again be assessed using the same validated scales for pain and disability, prior to injection and monthly thereafter, but for six months to extend the monitoring period to better define the limits of duration of effect.

For The Full Story:
http://clinicaltrials.gov/ct/show/NCT00404417?order=2


More news:

� Vaccination rate still low for teens despite uptick (2010-09-01)


� Drug-disposal bill gets Senate's nod (2010-08-24)

� High cholesterol common in younger adults, but screening rates remain low (2010-08-16)

� Patients' life circumstances an important factor in care (2010-08-12)

� Medicaid pay commission to begin work in September (2010-08-09)

� Verizon unveils Internet-based health information network (2010-08-06)

� Organized medicine should take leadership role in quality, study says (2010-08-05)

� Nixed Medicare consultation codes force doctors to make cutbacks (2010-08-02)

� Cholesterol screening recommended for all children (2010-07-30)

� Hospitals boost response rates for timely angioplasties (2010-07-29)